Technology

I recently had the pleasure to speak with Paul Edick, the Chairman and CEO of Xeris Pharmaceuticals, Inc., about Gvoke HypoPen®, a ready-to-use form of glucagon. As a person with type one diabetes, one of my biggest fears has always been low blood sugar. Thankfully, up to this point, I’ve always been able to treat my lows by myself by eating fast-acting carbohydrates. But what do you do when a person with diabetes has passed out from low blood sugar, or if eating carbs is not working to raise… Read more
Being able to sense changes in my blood sugar before it can potentially become dangerous has always been a struggle for me. Even after having type one diabetes for five years, I am still not able to recognize the signs and symptoms until it’s too late. When my endocrinologist introduced me to the magic of Continuous Glucose Monitors (CGM) my life changed completely. With an extra tool on my body, I was finally able to feel confident going to sleep, taking a shower, and hanging out with friends… Read more
Hi everyone! I’m Jenna and I’m a 2021 NextGen Fellow with CDN. I’ve been living with T1D for about 11 years and have been using a CGM for 6 of those years. Although I rely heavily on my CGM for daily management, I didn’t fully understand how I could use time in range to gain a better understanding of my daily blood sugar trends. Therefore, when the opportunity to interview Gary Scheiner, MS CDCES presented itself I thought it would be a great way to learn more about this topic. Gary is the… Read more
My diabetes routine has truly been transformed by Afrezza®. If you have been following along on my Instagram (@icedcoffeeandinsulin), you may have seen me talk about Afrezza®. Afrezza® is the only rapid acting insulin available that can be inhaled. With the proper balance of Afrezza® (rapid acting insulin) and Tresiba® (long-acting insulin), I have found a stable routine with MDI (multiple daily injections) that works best for me. If you are currently living with T1D, you know how… Read more
Medtronic has been releasing commercialized insulin pumps since 1983, but they’re still making innovations in 2020! They recently released their newest addition to the family – the MiniMed™ 770G system. This new insulin pump is able to work with the MiniMed™ MioTM Advance infusion set, which was released in the U.S. this past summer. Another new improvement with the pump is its ability to connect to smartphones through an app. The new insulin pump is a hybrid closed loop system like its… Read more
Glucagon Series Sponsored by Xeris Pharmaceuticals, Inc. & Lilly Diabetes.  Blog 4: Alleviating Fears Associated with Hypos Disclaimer: This blog is part of a series of blogs written by CDN students, alumni, and parents. CDN is committed to ensuring that young adults have the information they need to make informed choices about their healthcare. Given the recent innovations in glucagon, we wanted to highlight stories from our network about past experiences with lows, and how new treatment… Read more
Diabetes is never easy. It feels like that thing that’s constantly on your “to-do-list.” You can never seem to check it off; for some reason, it can’t be finished. One thing or another always seems to get in the way: you either get busy, tired…or forgetful from being busy and/or tired. It seems like a never-ending circle. A CGM (continuous glucose monitor), however, makes all of this just a little bit easier! It continuously monitors your glucose and shares all the data with the given reader.… Read more
In this new era of moving away from in-person medicine and transitioning to telehealth, when it comes to having diabetes and obtaining vital care, you may need some clarity on your options (pun intended). Continuous glucose monitors (CGMs) have been a revolutionary advancement in diabetes health management in recent years and have quickly been adapted into the lives of diabetics everywhere. This technology is ever-growing and expanding to meet the needs of its users. A lot of CGM’s offer… Read more
Glucagon Series Sponsored by Xeris Pharmaceuticals, Inc. & Lilly Diabetes.  Prompt: Blog 3: Student/Caregiver Relationship: As new rescue options emerge, the trust between us will grow. How does the risk of severe hypoglycemia affect your relationship with your caregiver? Disclaimer: This blog is part of a series of blogs written by CDN students, alumni, and parents. CDN is committed to ensuring that young adults have the information they need to make informed choices about their… Read more
I’m sitting on a small stool at my desk in my home office (my bedroom), wearing a dressy top and sweatpants, anxiously waiting for my Zoom call to start. My palms are sweaty, and I’ve nervously checked my Dexcom readings three times in the last five minutes. Professionally, I have worked with these calls daily since January of 2019. One might be wondering why this call is any different. This time, I was speaking with my PA-C care provider, whom I typically drive three hours to see in-person… Read more
Subscribe to Technology